Blueprint Medicines Corp
BPMC
ISIN null / Valor 27670715
Blueprint Medicines Corp
UMushroom community rating:
About company
Blueprint Medicines Corp is a global biopharmaceutical company dedicated to developing targeted therapies for patients with serious diseases, particularly in the areas of oncology, hematology, and allergy/inflammation. The company has successfully brought two medicines to market and maintains a robust pipeline of investigational treatments aimed at addressing the underlying causes of various conditions. Leveraging its deep biological expertise and advanced drug design capabilities, Blueprint Medicines focuses on precision medicine approaches to create innovative solutions. Additionally, the company supports its development efforts with comprehensive clinical and commercial infrastructure, enhancing its ability to advance and commercialize novel therapies effectively.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
8361 M
Market cap (USD)
Daily traded volume (Shares)
88.48 / 85.95
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
